Clinical Trial Update: Pharmacokinetics and Safety of Cefazolin 2g in DUPLEX [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics and safety of cefazolin at a 2 g dose in the DUPLEX protocol for infection. The trial investigates drug exposure a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• CEFAZOLIN (cefazolin sodium)

Snippet

Sponsor: B. Braun Medical Inc. | Conditions: Infection | Phase 1 | Status: COMPLETED